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Abstract 
 
Characterization of a novel mouse model with adipocyte-specific 
disruption via the aP2 promoter 
 
Meredith Riley First, MSNS 
The University of Texas at Austin, 2018 
 
Supervisor: Molly Bray 
 
Circadian rhythms, the behavioral and physiological daily changes that occur in the 
majority of organisms, are partially generated via cell-autonomous molecular clock 
mechanisms. The functions of these molecular clocks vary with tissue and cell type. To 
examine clock function specifically within adipose tissue, a mouse model with a mutant 
Clock gene linked to the aP2 promoter (aP2 clock mutant, ACM) was created. The ACM 
model was verified with real-time quantitative PCR (qPCR) of mRNA levels for multiple 
circadian genes in several tissue types collected at different time points. These ACM mice 
were then assessed based on several physiological and behavioral parameters. Adult ACM 
animals weighed more (F[14, 2657]=9.70, p<.001) and have higher body fat percentages 
(t[46]=-2.71, p<.01) compared to wildtype animals. ACM mice exhibited increased food 
intake (F[1,752]=5.23, p<.05), higher respiratory exchange ratio (F[1,524]=33.32, p<.001), 
and higher energy expenditure (F[1,524]=88.51, p<.001), despite increased weight gain 
compared to wild-type mice. ACM animals also demonstrated higher levels of leptin 
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(F[1,28]=4.72, p<.05) and non-esterified fatty acids (F[1,29]=8.23, p<.01). Tissue-specific 
disruption of the circadian clock appears to produce many of the phenotypes observed in 
global Clock mutant animals and suggests a critical role for tissues in which the aP2 
promoter is active in regulating global metabolism and energy balance.  
 v 
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 1 
Introduction 
The 24-hour day presents rhythmic, predictable patterns that include relatively 
static factors, such as the alteration between sunlight and darkness, as well as more 
variable, organism-dependent factors, such as meal timing and sleep cycles. The 
predictability of these patterns has led to the evolution of transcriptional molecular 
circadian clocks in almost all organisms, allowing for efficient cellular responses to 
repetitive environmental stimuli. Biological circadian rhythms are partially governed by 
these intrinsic transcriptional cellular clocks that are present in nearly all cell types. 
Rhythmic levels and frequency of expression of circadian genes and proteins influence 
transcription of downstream genes and execution of multiple cellular functions, including 
hormone release, metabolism, and behavior.1,2 
The circadian clock is comprised of positive and negative feedback loops that 
depend upon the transcription, translocation, activity, and degradation of various circadian 
genes and proteins.3 The main positive feedback loop is driven by the transcription and 
action of the circadian locomotive output cycles kaput (Clock) and aryl hydrocarbon 
receptor nuclear translator-like (Arntl or Bmal1) genes.4 Once translated, CLOCK and 
BMAL1 proteins heterodimerize, translocate to the nucleus, and bind to E-box elements 
within the promoter regions of several genes, including the genes that encode them, thereby 
activating their own transcription.3,5 Other clock genes include the Period family (Per1, 
Per2, and Per3), Cryptochrome family (Cry1 and Cry2), as well as Retinoic acid orphan 
receptor alpha (Rora), and Nuclear receptor subfamily1 group D (Nr1d2 or Rev-erba).3,5 
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Once translated, PER and CRY proteins can also form a heterodimer (along with casein 
kinase I epsilon) and translocate to the nucleus, forming the negative loop of the clock 
mechanism that results in downregulation of the transcription of Per and Cry genes.6 
Degradation of PER and CRY proteins allows for the BMAL1/CLOCK heterodimer to 
again predominate, and the cycle begins again. Interactions of RORA and REV-ERBa 
form accessory positive and negative feedback loops, respectively. RORA enhances Bmal1 
transcription by interacting with ROR elements; conversely, interaction of REV-ERBa 
with ROR elements inhibits expression of Bmal1, which results in downregulation of its 
own expression.7 
The circadian transcriptional mechanism is found nearly ubiquitously in all 
mammalian cells. Various investigations have been conducted in order to elucidate 
circadian clock function by inducing its disruption via genetic manipulation. Many 
transgenic animal models that disrupt circadian clocks do so indiscriminately, affecting all 
cells, and involve the alteration of global circadian gene expression. A widely studied 
model of circadian clock disruption is the dominant negative ClockD19/D19 model, producing 
a Clock mutant gene that lacks the transactivation domain due to the loss of exon 19.8,9 
Mice with global ClockD19 mutations have phenotypes characteristic of the metabolic 
syndrome, including obesity, hyperphagia, hyperleptinemia, hypoinsulinemia, 
hyperglycemia, and hyperlipidemia.10  
Although the general components and mechanisms of the cellular clock are the 
same across cell types, the functions of cell-specific clocks have been shown to vary.11,12 
Because increased adiposity and metabolic dysfunction are central to global ClockD19 
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mutant animals, we created a tissue-specific mouse model in which the ClockD19 mutation 
is driven by the fatty acid-binding protein 2 (aP2) promoter, which is predominantly active 
in adipocytes. The mutated dnClock gene is highly overexpressed in this aP2 Clock Mutant 
(ACM) model, causing the dnCLOCK protein to preferentially bind to BMAL1 over the 
endogenous CLOCK, thereby creating a non-functional heterodimer and a resultant tissue-
specific disrupted circadian cycle. This mouse model shows circadian disruption in 
primarily adipose tissue and does not exhibit whole body circadian disruption, allowing for 
a more detailed examination of the function of the cellular clock within adipocytes. Here 
we report the primary phenotypes associated with the ACM animal model.  
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Materials and Methods 
Animals 
Both ACM mice and wild-type (WT) littermates on the FVB/N background were 
housed at the Children’s Nutrition Research Center at Baylor College of Medicine or at the 
Center for Comparative Medicine at the University of Alabama at Birmingham. All studies 
and protocols were approved by their respective Institutional Animal Care and Use 
Committees. Mice were housed in standard micro-isolator cages (except during feeding 
studies, during which they were housed on wire-bottom cages or within a Comprehensive 
Lab Animal Monitoring System (CLAMS)), within a controlled environment, including a 
12:12 hour light-dark cycle with temperature maintained at 23±1°C. Food and water were 
provided ad libitum, unless otherwise specified. Transgenic ACM mice were created via 
pronuclear injection of a dnClock construct lacking exon 19 that was driven by the aP2 
promoter. The aP2 promoter is primarily expressed in adipocytes; however, it has also been 
shown to have low activity in macrophages, dendritic cells, and cardiomyocytes.13 
Genotypes were verified using the following primers: 5’-
ATTGTTCACTCCTACAGTCAC and 5’-CCAGGAAGCATAGACCCCAGC. 
Dissections 
Male ACM and WT mice were anesthetized with pentobarbital prior to drawing of 
blood and subsequent removal of the heart, liver, adipose tissue (peri-gonadal, 
subcutaneous, and brown), and muscle (gastrocnemius) samples. Tissues were dissected 
every 3 hours for 24 hours. During dissections, zeitgeber time (ZT) conditions were 
maintained, with ZT0 defined as the time lights were turned on and ZT12 as the time lights 
turned off.   
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Quantitative PCR 
qPCR was performed using methods previously described.14-16 qPCR data are 
represented as mRNA molecules per microgram of total RNA. Primer and probe sequences 
for Bmal1 and Clock have been published previously.16 
Growth and Hormone Measurements 
Daily food intake was monitored manually during feeding protocols. Body weights 
were measured weekly. Body composition measures were performed in mice 5-6 months 
of age using a Lunar PIXImus Densitometer (GE Medical Systems, Madison, WI). Non-
fasted plasma glucose, non-esterified fatty acids, insulin, triglycerides, and leptin 
concentrations were measured using commercially available kits (Thermo Scientific, 
Waltham, MA; Wako Diagnostics, Richmond, VA; CrystalChemInc., Downers Grove, IL; 
Linco Research, Inc., St. Charles, MO). 
Feeding Studies 
Mice were fed either a standard chow (Harlan, cat. No. Teklad 7917), a low fat 
(10% kcals fat, LF, Research Diets, D12450B), a high fat (45% kcals fat, HF, Research 
Diets, D12451), or a very high fat (60% kcals fat, VHF, Research Diets, D12492) diet. All 
non-standard diets were matched for protein content and macronutrient quality. Access to 
food was either ad libitum or a specialized protocol was used to simulate “meals” of 
different compositions presented at distinct times during the active phase (ZT12-ZT24). 
This phase was divided into three four-hour time periods, and four-hour “meals” were 
provided at the beginning (ZT12-ZT16) and end (ZT20-ZT24) of the active phase, 
separated by 4 hours (ZT16-ZT20) of food restriction. The feeding paradigm consisted of 
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either a HF/VHF waking “meal” (ZT12-ZT16) combined with a LF “meal” during the last 
4 hours of the waking period (ZT20-ZT24), or the opposite meal order.  
GTTs 
Glucose tolerance tests (GTT) were performed for the three experimental feeding 
protocols. GTTs were performed at 6, 10, 12, and 20-23 weeks of age. Prior to each GTT, 
animals were fasted for 10 hours. Tails were nicked, and baseline plasma glucose 
measurements were taken using a Freestyle glucometer. Animals were injected 
intraperitoneally with 10% D-glucose (0.01 ml/g). Plasma glucose levels were measured 
at 15, 30, 60, 90, and 120 minutes after injection.  
Metabolic Measures 
ACM and WT mice were placed into individual cages in a Comprehensive Lab 
Animal Monitoring System (CLAMS) for one week. Throughout the week, lights were 
turned on at 8 am (ZT0) and turned off at 8 pm (ZT12), and temperature was maintained 
at 25±1.5°C. After a three-day acclimation period, the CLAMS recorded data on 
respiratory exchange ratio (RER), energy expenditure (EE), food intake, and physical 
activity (measured by beam breaks along two planes). Data were recorded every 15 minutes 
and were categorized into light (ZT0-ZT12) or dark (ZT12-ZT24) time periods. Food 
intake and movement were summed across these time periods per day and averaged across 
days. EE and RER were averaged per time period, then averaged across days. 
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Data Analysis 
Unless otherwise specified, all statistical analyses were performed using StataSE 13 
(StataCorp, College Station, TX). The area under the curve (AUC) was determined for 
GTTs. Analysis of covariance (ANCOVA) was used to determine main effects and 
interactions, and significant results were followed with post hoc tests using the Bonferroni 
correction method in order to maintain a family-wise error rate of p<0.05. Cosinor analyses 
were performed to examine rhythmicity of gene expression and metabolic data.  
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Results 
Creation and Verification of the ACM Model 
In order to verify the ACM model, various tissues were collected from mice at a 
single ZT point, and qRT-PCR was performed on Clock mRNA. Results include both 
endogenous Clock and dnClock mRNA (Figure 1). No significant differences were 
observed between WT and ACM animals in kidneys or in livers. In all of the tissues with 
differential Clock expression, ACM mice had greater Clock+dnClock mRNA than WT 
animals. In muscle and heart tissue, expression of Clock+dnClock mRNA was 
approximately two-fold higher in the ACM mice (muscle: 529±233; heart: 787±50, 
p<0.05) compared to WT mice (muscle: 152±40; heart: 393±14). On the other hand, 
Clock+dnClock expression levels in subcutaneous tissue (SAT) and visceral fat (VAT) of 
ACM mice were 13-24 fold higher than those of WT mice (SAT: 4933±2190; VAT: 
4002±1857 vs. SAT: 201±56; VAT: 315±80, respectively, p<0.05).  
 In order to examine clock genes over time, qRT-PCR was performed for the 
circadian genes Clock and Bmal1 in white and brown adipose tissue across eight ZTs, each 
three hours apart (Figure 2). Analyses revealed a significant effect between genotypes for 
Clock+dnClock (F(7,59)=102.51, p<.001) with ACM mice having constitutively higher 
levels of Clock mRNA (3315±1715) than WT mice (423±165). Due to their oscillatory 
nature, a significant main effect of ZT was seen for Bmal1 ( F(7,57)=8.62, p<.001), but no 
such main effects were apparent between genotypes for Bmal1 (F(5,57)=0.46, p>.05). 
Because ACM mice appeared to have an advance in peak expression of Bmal1 compared 
to WT (ZT 18 vs. ZT 24, respectively), cosinor analysis was performed to test for a 
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significant phase advance in ACM Bmal1 expression. Based on R-squared values, a non-
linear model explained approximately 45% of the variance in WT compared to 47% of the 
variance in ACM mice. Parameters of the model were not significantly different between 
genotypes.  
Effects of Genotype and Feeding on Body Composition 
Because the disruption of clocks in ACM animals is primarily localized to 
adipocytes, total body weight and adiposity were examined (Figure 3). At five months of 
age, ACM mice had higher fat percentages than WT mice (22.1±4.3 % vs.17.8±3.8 %, 
respectively; p>0.05). In 10-month-old mice, there were no differences in total body 
weight, but there were significant differences in body fat (t(46)=-2.71, p<.01); again, ACM 
mice had significantly higher fat percentages than WT mice (29.6±9.8 vs. 23.6±5.0, 
respectively). 
 To test for trends in weight gain between ACM and WT mice, monthly body weight 
data were compared in mice that had not been used in any experiments, had lived to at least 
one year of age, and had been weighed at least once per month (Figure 4). A significant 
main effect of genotype (F(1, 173)=10.51, p<.01) and a main effect of age (F(16, 
2657)=2601, p<.001), as well as an interaction of genotype and age (F(14, 2657)=9.70, 
p<.001) were all observed.  
 To examine whether these differences in body weight were associated with food 
intake, young male mice were fed either LF or HF diets, matched for protein intake, for 
one month. At three to four months of age, body fat and total weight were measured (Figure 
 10 
5). For body fat, a main effect was seen both for diet (F(1,12)=10.61, p<.01) and for 
genotype (F(1,12)=5.92, p<.05), with ACM mice and those fed high fat chow having higher 
adiposity measures.  
 Based on our previous work demonstrating that timing of feeding is important in 
metabolic response to high fat diets, ACM and WT mice were exposed to the feeding 
schedule consisting of two 4-hour “meals” at the beginning and end of the waking period, 
one during which they were given either HF or VHF food, and the other during which they 
were given LF chow. After 15 weeks on this feeding schedule, body composition and 
weight measures were assessed (Figure 6). Groups were categorized based on genotype 
(ACM vs. WT), diet (HF and LF vs. VHF and LF), and timing of access to the high fat 
chow (early vs. late). Total body weight showed a main effect of genotype (F(1,39)=5.30, 
p<.05). ACM mice tended to have higher weight overall (38.4±4.0 g) than WT mice 
(38.4±4.0 g) (36.1±3.2 g), with the effect being especially apparent for the late very high 
fat feeding group, in which ACM mice weighed over five grams more (41.2±2.6 g) than 
WT mice (34.7±3.9 g).  
Body fat percentage also showed a main effect of genotype (F(1,39)=8.59, p<.01). 
Consistent with the patterns in weight, ACM mice had higher fat (34.0±5.1%) than WT 
mice (30.3±3.8%) overall, but this difference was especially apparent for those given late 
access to very high fat chow, with ACM mice having a higher percent fat (37.1±3.5 %) 
than WT mice (28.0±5.1 %).  
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Effects of Genotype and Feeding on Glucose Tolerance 
In WT and ACM mice at 6-7, 10, 13-14 and 20 weeks of age fed standard chow ad 
libitum, there were no significant differences observed between genotype groups in AUC 
or glucose values over time at any age.  
For animals in the EVHF and EHF groups that were fed according to the 4-hour 
“meal” paradigm, no significant genotype difference was observed in AUC or in glucose 
over time (Figure 7 A&C).  In the late fat groups (LVHF and LHF), a significant genotype 
difference was observed in glucose values over time (Figure 7 B&D LVHF: 232.78±8.62 
mg/dl vs. 283.19±14.54 mg/dl LHF: 245.40±14.62 mg/dl vs. 282.81±12.94 mg/dl; WT and 
ACM, respectively).  
Analysis of Behavioral and Physiological Changes 
In order to explore potential causes for the discrepancies in weight and body fat 
between WT and ACM mice, eight of each genotype were placed into a CLAMS to 
determine daily trends for food intake, activity, energy expenditure (EE), and respiratory 
exchange ratio (RER). Collected data was divided into three-hour time periods. Food and 
movement were totaled for each time period, while EE and RER were averaged (Figure 8).  
 A main effect of genotype was seen for food intake (F(1,752)=5.23, p<.05), with 
ACM mice eating more than WT mice overall. There was also a main effect of time period 
on food intake (F(7,752)=14.87, p<.001) (Figure 8A). Activity did not show a main effect 
of genotype, but did exhibit a main effect for time period (F(1,524)=19.02, p<.001) (Figure 
8C). RER had significant main effects of both time period (F(7,524)=14.54, p<.001) and 
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genotype (F(1,524)=33.32, p<.001), with ACM mice showing more energy utilization from 
carbohydrate versus fat metabolism than WT mice (Figure 8B). EE showed a main effect 
for both time period (F(1,524)=41.98, p<.001) and genotype (F(1,524)=88.15, p<.001), 
with ACM mice exhibiting greater expenditure than WT mice (Figure 8D).  
 To further examine potential contributors to the increases in body fat and weight 
seen in ACM mice, several blood analytes, including leptin, cholesterol, non-esterified 
fatty acids (NEFA), and triglycerides, were analyzed (Figure 9). These analytes were 
measured through blood samples collected at four different ZT points. No significant 
effects of genotype or time were seen for cholesterol or for triglycerides (Figures 9A and 
9B). For leptin, a main effect of genotype was apparent (F(1,28)=4.72, p<.05), with ACM 
mice having higher average levels (14.2±13.3 ng/ml) of leptin than WT mice (5.8±3.5 
ng/ml), with a striking surge of leptin at ZT18 (Figure 9C). Main effects of both genotype 
(F(1,29)=8.23, p<.01) and time (F(5,29)=3.73, p<.01) were apparent for NEFA levels. 
NEFA levels tended to be higher in ACM mice (0.25±.09 mE/L) than in WT mice 
(0.20±.05 mE/L) (Figure 9D).   
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Discussion 
The creation of an adipocyte specific circadian disruption model was achieved via 
a dominant negative Clock gene lacking the normal transactivation domain, the 
transcription of which is linked to the aP2 promoter. This model was verified by the 
significant overexpression of Clock mRNA seen primarily in fat tissues. Although 24-hour 
disruption of Bmal1 was not apparent, this observation could be due to maintained 
rhythmicity of non-adipocyte cell types within the sample. The significance of a phase 
advance in peak Bmal1 is not known.  
ACM mice fed normal chow tended to weigh more than their WT counterparts, a 
trend that was exacerbated after the animals reached adulthood (approximately 3 months 
of age). Differences in adiposity were more profound and also appeared to be exaggerated 
with age, with adult ACM mice having higher body fat than WT animals. The results seem 
to mimic phenotypes observed in global knockouts, although to a lesser extent.10 These 
effects on body weight and body composition were not highly influenced by a change in 
the fat content of diet, as both genotypes seemed to increase the same amount of weight 
and body fat due to the increase in fat intake. However, the introduction of a varied diet 
and an even higher fat chow did elicit markedly different responses between the two 
genotypes. ACM mice were particularly sensitive to a timed feeding regimen that included 
exposure to very high fat meal at the end, but not the beginning, of their active period. With 
exposure to normal chow diets, ACM mice demonstrated higher food intake, as well as 
higher RER, indicating increased reliance on energy from carbohydrate metabolism than 
stored fat metabolism. The difference in RER between genotypes trended toward an 
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interaction with time, and reliance on carbohydrate metabolism appeared to be especially 
apparent toward the end of the dark period. In addition, ACM mice tended to have higher 
energy expenditure than WT mice, although there were no differences in activity levels 
detected between genotypes.  
The adipokines measured (leptin, cholesterol, triglycerides, and NEFAs) were all 
associated with the amount and activities of adipose tissue. Leptin is a hormone that acts 
as a satiety signal, and therefore, is implicated in the regulation of body weight and energy 
balance.17 High levels of serum cholesterol are associated with overweight/obesity and 
atherosclerotic risk.18,19 High triglycerides are associated with insulin resistance, 
cardiovascular disease, and metabolic syndrome.20 NEFAs are fatty acids that can be 
synthesized endogenously by the organism, and levels are elevated in obesity.21 
Interestingly, leptin levels of ACM mice spiked at later time points (ZT18) of the dark 
period, concomitant with observed increases in food intake at this phase. This incongruous 
pairing of increased intake despite elevated satiety signaling may indicate a time-dependent 
leptin resistance in ACM mice, leading to impaired metabolism in the late phase and their 
metabolic syndrome-like phenotype. The observed increases in NEFA corroborate this 
hypothesis, signaling a time-dependent impairment of fat metabolism in the ACM mice. 
Though there were no evident defects in glucose tolerance in the ACM animals, the 
differences in EE, RER, and leptin levels observed with adipocyte clock disruption have 
implications in energy balance outcomes.  
The collection of these data suggests that several aspects of the metabolic 
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syndrome-like phenotype observed in animals with global Clock disruption are at least 
partially attributable to disruption specifically within adipocytes. Continued examination 
of the physiological differences of ACM mice both at baseline and after dietary 
manipulations is warranted to elucidate the roles of the circadian clock in adipocytes.  
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Figures 
 
 
 
 
 
Figure 1: qRT-PCR for Clock+dnClock in various tissues. Significant differences in 
Clock+dnClock mRNA levels were observed in gastrocnemius (muscle), heart, 
subcutaneous tissue (SAT), and visceral fat (VAT). Compared to other tissues, the 
adipocyte-derived tissues have significantly higher Clock+dnClock expression.  
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Figure 2: qRT-PCR for A. Clock+dnClock and B. Bmal1 in white adipose tissue. A main 
effect of genotype was seen for Clock+dnClock mRNA levels. No significant main effects 
or interactions involving genotype were present in Bmal1 mRNA. 
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Figure 3: A. Body weight and B. body fat measures in adult (5-6 months) and aged (10 
months) animals of each genotype. No differences were seen between genotypes for total 
body weight of male mice approximately five months of age. The difference in body fat 
percentage was trending toward significance; t(23)=-2.03, p=.054; with ACM mice 
showing slightly higher body fat than WT mice.  
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Figure 4: Weight comparisons of ACM and WT mice. Weight data were collected from 
male mice >1 year of age who had not undergone any other experimental procedures and 
had only been given standard chow ad libitum. A significant main effect was seen for both 
genotype and age, as well as an interaction between the two. The post hoc tests per age 
group revealed significant differences being maintained in four of the fifteen age segments. 
#=pFW<.05, ***=p<.001. 
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Figure 5: A. Body weight and B. body fat measures in ACM and WT mice fed LF or HF 
chow ad libitum. No significant effects for body weight were seen for diet or genotype. 
Main effects of genotype (p<.05) and diet (p<.01) were seen for body fat percentage, with 
the high fat diet and ACM genotype being associated with higher body fat. *=p<.05, 
**=p<.01.  
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Figure 6: A. Body weight and B. body fat measures in ACM and WT mice fed two 4-hour 
“meals” separated by a 4-hour phase of food restriction for 15 weeks. Mice were fed a 
combination of high fat (HF) or very high fat (VHF) in combination with low fat food. 
They were given early access to one food type during the first four hours of their dark 
period (ZT12-16), and late access to the other food type during the last four hours of dark 
(ZT20-24). Groups are divided by timing of access to the fatty chow (HF or VHF), 
genotype, and which high fat chow was received. A main effect of genotype was seen for 
weight, with ACM mice showing higher weight than WT mice (A). Similar results were 
seen for body fat, with a main effect for genotype, and ACM mice having higher body fat 
than WT mice (B). *=p<.05, **=p<.01. 
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Figure 7: GTT results by Genotype post-short-term time restricted feeding: A. EVHF B. 
LVHF C. EHF D. LHF. Results shown as mean +/- sem.  *genotype effect p<0.05 
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Figure 8: CLAMS behavioral and physiological measures in ACM and WT mice. Data were 
recorded for A. food intake, B. respiratory exchange ratio (RER), C. activity, and D. energy 
expenditure (EE). The data were divided into three-hour segments. Food intake and movement 
values were summed across these periods, while RER and EE were averaged. Main effects of 
genotype and Zeitgeber time (ZT) for food intake were observed, with ACM mice eating more than 
WT mice. There were main effects of genotype and ZT for RER, as well as a trend toward an 
interaction (F[7,524]=1.97, p=.057). RER values were closer to 1.0 in ACM animals, indicative of 
greater reliance on carbohydrate metabolism than stored fat metabolism compared to WT mice. No 
main effect of genotype, but a main effect of ZT, was observed for activity. A significant main 
effect of genotype was observed with EE, with ACM mice having higher EE values than WT mice 
overall. *=p<.05, ***=p<.001.  
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Figure 9: Adipokine levels at four different ZT points. No main effects of genotype or time 
for A. cholesterol or B. triglycerides were observed. C. ACM animals had higher leptin 
levels compared to WT. D. Main effects of genotype and time were observed for NEFA 
levels. *=p<.05, **=p<.01.  
 
  
 
 25 
References 
1. Hastings M, O'Neill JS, Maywood ES. Circadian clocks: regulators of endocrine 
and metabolic rhythms. The Journal of endocrinology. 2007;195(2):187-198. 
2. Kohsaka A, Laposky AD, Ramsey KM, et al. High-fat diet disrupts behavioral and 
molecular circadian rhythms in mice. Cell metabolism. 2007;6(5):414-421. 
3. Takahashi JS. Molecular components of the circadian clock in mammals. Diabetes, 
obesity & metabolism. 2015;17 Suppl 1:6-11. 
4. Lande-Diner L, Boyault C, Kim JY, Weitz CJ. A positive feedback loop links 
circadian clock factor CLOCK-BMAL1 to the basic transcriptional machinery. 
Proceedings of the National Academy of Sciences of the United States of America. 
2013;110(40):16021-16026. 
5. Kondratov RV, Gorbacheva VY, Antoch MP. The role of mammalian circadian 
proteins in normal physiology and genotoxic stress responses. Current topics in 
developmental biology. 2007;78:173-216. 
6. Duong HA, Robles MS, Knutti D, Weitz CJ. A molecular mechanism for circadian 
clock negative feedback. Science (New York, NY). 2011;332(6036):1436-1439. 
7. Guillaumond F, Dardente H, Giguere V, Cermakian N. Differential control of 
Bmal1 circadian transcription by REV-ERB and ROR nuclear receptors. Journal 
of biological rhythms. 2005;20(5):391-403. 
8. King DP, Zhao Y, Sangoram AM, et al. Positional cloning of the mouse circadian 
clock gene. Cell. 1997;89(4):641-653. 
 26 
9. Vitaterna MH, King DP, Chang AM, et al. Mutagenesis and mapping of a mouse 
gene, Clock, essential for circadian behavior. Science (New York, NY). 
1994;264(5159):719-725. 
10. Turek FW, Joshu C, Kohsaka A, et al. Obesity and metabolic syndrome in circadian 
Clock mutant mice. Science (New York, NY). 2005;308(5724):1043-1045. 
11. Bray MS, Young ME. The role of cell-specific circadian clocks in metabolism and 
disease. Obesity reviews : an official journal of the International Association for 
the Study of Obesity. 2009;10 Suppl 2:6-13. 
12. Ramanathan C, Xu H, Khan SK, et al. Cell type-specific functions of period genes 
revealed by novel adipocyte and hepatocyte circadian clock models. PLoS genetics. 
2014;10(4):e1004244. 
13. Makowski L, Boord JB, Maeda K, et al. Lack of macrophage fatty-acid-binding 
protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat 
Med. 2001;7(6):699-705. 
14. Gibson UE, Heid CA, Williams PM. A novel method for real time quantitative RT-
PCR. Genome research. 1996;6(10):995-1001. 
15. Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome 
research. 1996;6(10):986-994. 
16. Bray MS, Shaw CA, Moore MW, et al. Disruption of the circadian clock within the 
cardiomyocyte influences myocardial contractile function, metabolism, and gene 
expression. American journal of physiology Heart and circulatory physiology. 
2008;294(2):H1036-1047. 
 27 
17. Paz-Filho G, Mastronardi CA, Licinio J. Leptin treatment: facts and expectations. 
Metabolism: clinical and experimental. 2015;64(1):146-156. 
18. Hansson GK, Libby P. The immune response in atherosclerosis: a double-edged 
sword. Nature reviews Immunology. 2006;6(7):508-519. 
19. Glass CK, Witztum JL. Atherosclerosis. the road ahead. Cell. 2001;104(4):503-
516. 
20. Joseph J, Shamburek RD, Cochran EK, Gorden P, Brown RJ. Lipid regulation in 
lipodystrophy versus the obesity-associated metabolic syndrome: the dissociation 
of HDL-C and triglycerides. The Journal of clinical endocrinology and metabolism. 
2014;99(9):E1676-1680. 
21. Reddy NL, Peng C, Carreira MC, et al. Enhanced thermic effect of food, 
postprandial NEFA suppression and raised adiponectin in obese women who eat 
slowly. Clinical endocrinology. 2015;82(6):831-837. 
 
